Reviews/Dietary Protein and Muscle/Protein supplement aids training gains

Training Adaptations · DPM-TRA-01 · v2

Protein supplementation augments resistance-training muscle mass and strength gains

LikelyStanding · 70–84% 72%Evidence certainty 13Papers in corpus 21 Oct 2026Last reviewed

Borderline: within 4 points of the Likely/Uncertain boundary, so a re-grade could land either side.

Where the evidence stands.

Across twelve resistance-training trials, adding protein never hurt muscle or strength gains, and several studies found it helped. The clearest benefits appeared in older or sarcopenic adults [1][9][12] and when diet was tightly controlled [4]. In younger adults who already ate plenty of protein, trials that compared protein against an equal-calorie drink repeatedly found no extra benefit [2][3][6][13]. Some of the strongest positive results compared protein against plain water or an unsupplemented group, so added calories rather than protein itself may explain part of the gain [7][8]. The panel concluded the effect is real but modest and depends heavily on who is supplementing and what they already eat, rather than being a uniform boost for everyone.

Several well-conducted RCTs show a between-group advantage for protein on muscle mass and strength, concentrated in older women [1][12] and sarcopenic elderly men [9], and present even under matched dietary energy intake [4]. The direction of effect across the corpus is consistently non-negative. However, young-adult trials using genuinely isocaloric comparators find no additive benefit: [2] versus carbohydrate, [3] versus maltodextrin with no myofiber hypertrophy, [6] reporting 'no additive benefit', and [13] normal versus high-protein diet. Two further positives [9][11] rely on collagen peptides rather than conventional whole protein. The contested point: The division is whether the increment over an active, energy-matched control is a genuine protein effect or an artifact of population and comparator. Positives cluster where baseline intake is low, populations are older, or comparators are not isocaloric [7][8]; isocaloric young-adult trials null out [2][3][6][13].

Get the full review

All 13 papers behind this claim with their DOIs and what each does to it, the panel’s arbitration, the evidence gap map and the open research questions. Free, and sent to your inbox.

We’ll also send you other claims from Dietary Protein and Muscle, one at a time, and tell you when a release or a pivotal trial changes a grade. Unsubscribe by replying.

See a sample full review →

The sceptic's challenge.

One reviewer's only job is to attack the finding. The challenges below were weighed before the grade was set.

Isocaloric young-adult trials find no effect

Every young-adult trial with a genuinely isocaloric comparator finds no between-group effect: [2] vs carbohydrate, [3] vs maltodextrin (no myofiber hypertrophy), [6] vs placebo ('no additive benefit'), [13] normal vs high protein. The positive signal is not universal.

Strongest positives carry energy confounds

The strongest positive trials are energy-confounded: [7] chocolate milk adds calories and carbohydrate against an unsupplemented RT-only arm, and [8] compares protein against water — an energy rather than protein effect is not excluded.

Where it remains uncertain. Young-adult trials with isocaloric comparators find no additive benefit [2][3][6][13], and the strongest positives compare against water or an unsupplemented arm so an energy effect is not excluded [7][8].

Aleatory

Small, short samples

All trials are N=18–70 over 4–12 weeks, so between-subject variability and limited power leave true increments imprecise [2][6][13].

Epistemic

Energy confounding

Positives [7][8] compare protein against an unsupplemented arm or water, so added calories rather than protein cannot be excluded as the cause.

Inferential

Population generalisation

Benefit concentrates in older/sarcopenic adults [1][9][12] and low-intake contexts [2]; extending this to a general population is an inference the corpus does not uniformly support.

The papers the grade rests on.

The load-bearing papers from a corpus of 13, each classified by what it does to the claim. Every DOI is taken from the corpus the claim was graded on.

SupportsNabuco 2018RCT · primary evidence

Supports augmentation of both mass and strength over placebo in older women.

“A time vs. group interaction ( p < 0.05) was observed with WP-PLA and PLA-WP presenting greater increases compared with PLA-PLA for SMM (WP-PLA = 3.4%; PLA-WP = 4.2%; PLA-PLA = 2.0%), strength (WP-PLA = 8.1%; PLA-WP = 8.3%; PLA-PLA = 7.0%)”

Panel auditInternal validity: medium · scope of inference: Pre-conditioned older women already habituated to resistance training, 12 weeks, 35 g whey.Key limitations: older women only · pre-conditioned subjects · 12-week duration · blinding not stated

10.3390/nu10050563 →

NeutralVangsoe 2018RCT · primary evidence

Counter-evidence: null against isocaloric carbohydrate, attributed to adequate habitual intake.

“No significant differences in body composition and muscle strength improvements were found between groups.”

Panel auditInternal validity: medium · scope of inference: Young healthy men with high habitual protein intake, 8 weeks, insect protein vs carbohydrate.Key limitations: small sample · comparator is carbohydrate not placebo · high habitual protein intake · insect protein specific

10.3390/nu10030335 →

NeutralReidy 2017RCT · primary evidence

Supports a modest lean-mass effect while finding no myofiber hypertrophy effect — bounds the magnitude.

“Protein supplementation during resistance training has a modest effect on whole-body lean mass as compared with exercise training without protein supplementation”

Panel auditInternal validity: medium · scope of inference: Healthy young men, 12 weeks, 22 g protein, whole-body lean mass and myofiber-level outcomes.Key limitations: borderline significance · no strength outcome in abstract · no myofiber hypertrophy benefit · young men only

10.1249/mss.0000000000001224 →

SupportsYapici 2023RCT · supporting context

Significant group x time interactions showed larger increases in muscle thickness, 1RM and peak power in the chocolate-milk group.

Panel auditInternal validity: low · scope of inference: Untrained young men, 8 weeks, 500 mL chocolate milk (30 g protein).Key limitations: no isocaloric placebo · unblinded · small sample · untrained men only

10.3389/fphys.2023.1148494 →

4 of 13 papers shown. The full review lists all of them, with the panel’s arbitration →

How this grade has moved.

Claims are graded at each quarterly release, and re-graded between releases only when a pivotal trial lands. Every change is a new version of the claim.

Release 2026-q360%Uncertainearlier protocol

Graded under an earlier protocol; not comparable number for number

21 Oct 202672%Likelyrelease 2026-q4

Preponderance of RCT evidence supports a modest augmenting effect, but substantial well-controlled nulls and confounded positives cap confidence at the lower edge of Likely.

13 papers in corpus · 12 bear on the claim

Release 2026-q4 re-graded every claim from its corpus under protocol v0.19. An earlier release's grade is shown for the record; it came from an earlier protocol and is not a movement.

What the grade is leaning on.

Assumptions that carry weight but are not themselves established.

ContestedPositive effects in [7] and [8] reflect protein rather than added energy from non-isocaloric comparators
ContestedCollagen peptide results generalise to conventional whole-protein supplementation
ContestedThe augmentation seen in older/sarcopenic adults extends to young adults with adequate habitual intake
UnverifiedShort 4–12 week trials capture the true magnitude of between-group increments
Partially verifiedMuscle mass and strength are augmented together rather than dissociably

What would change this.

The panel records the gap that would most move the claim, and the study that would close it.

Isocaloric protein benefit in young adults. Every isocaloric young-adult trial here nulls [2][3][6][13], yet positives exist only in older or non-isocaloric designs, leaving the protein-specific effect in well-fed young adults unresolved. The panel rates this the highest-importance open gap for the claim, and names the study design that would close it: Adequately powered RCT in young trained adults with verified habitual intake, protein versus isocaloric non-protein comparator, co-primary muscle mass and strength outcomes.

Open question: Does conventional protein supplementation augment muscle mass and strength in young adults with adequate habitual intake when compared against an isocaloric control? Why it is still open: All isocaloric young-adult trials in the corpus found no between-group difference [2][3][6][13], while positives came from older or non-isocaloric designs.

Priors is a sceptical first reader, not peer review, and not medical advice.

Release 2026-q4 · graded 21 Oct 2026 · protocol v0.19